We are live on ! Find out more
HWAM

Hennion & Walsh Asset Management Portfolio holdings

AUM $3.5B
1-Year Est. Return 41.95%
This Fund
S&P 500
This Quarter Est. Return
+4.77%
1 Year Est. Return
+41.95%
3 Year Est. Return
+93.92%
5 Year Est. Return
+100.55%
10 Year Est. Return
AUM
$2.9B
AUM Growth
+$137M
Cap. Flow
+$88.8M
Cap. Flow %
3.06%
Top 10 Hldgs %
17.97%
Holding
1,008
New
71
Increased
442
Reduced
400
Closed
82

Sector Composition

Rank Sector Weight
1 Technology 12.53%
2 Healthcare 11.66%
3 Financials 9.01%
4 Industrials 7.22%
5 Consumer Discretionary 3.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MYI icon
26
BlackRock MuniYield Quality Fund III
MYI
$719M
$16.9M 0.58%
1,554,195
+12,912
+0.8% +$142K
NZF icon
27
Nuveen Municipal Credit Income Fund
NZF
$2.43B
$16.7M 0.58%
1,327,751
-248,763
-16% -$3.13M
MQY icon
28
BlackRock MuniYield Quality Fund
MQY
$815M
$16.1M 0.56%
1,428,403
+370,808
+35% +$4.26M
ADI icon
29
Analog Devices
ADI
$187B
$15.7M 0.54%
57,927
+3,683
+7% +$925K
AMAT icon
30
Applied Materials
AMAT
$415B
$15.1M 0.52%
58,821
+2,184
+4% +$524K
LLY icon
31
Eli Lilly
LLY
$1.1T
$15.1M 0.52%
14,055
-430
-3% -$411K
KLAC icon
32
KLA
KLAC
$252B
$14M 0.48%
115,370
-6,750
-6% -$792K
JPM icon
33
JPMorgan Chase
JPM
$956B
$13.4M 0.46%
41,479
+2,962
+8% +$917K
META icon
34
Meta Platforms (Facebook)
META
$1.52T
$12.9M 0.45%
19,595
+907
+5% +$606K
EIM
35
Eaton Vance Municipal Bond Fund
EIM
$499M
$12.8M 0.44%
1,312,796
+69,261
+6% +$685K
BTT icon
36
BlackRock Municipal 2030 Target Term Trust
BTT
$1.44B
$12.4M 0.43%
542,733
+31,848
+6% +$717K
LRCX icon
37
Lam Research
LRCX
$383B
$12.2M 0.42%
71,213
+3,750
+6% +$583K
NXP icon
38
Nuveen Select Tax-Free Income Portfolio
NXP
$895M
$12M 0.41%
852,505
-68,062
-7% -$978K
COGT icon
39
Cogent Biosciences
COGT
$7.1B
$12M 0.41%
338,065
+37,938
+13% +$1.07M
GE icon
40
GE Aerospace
GE
$380B
$11.9M 0.41%
38,568
+9,095
+31% +$2.74M
NMZ icon
41
Nuveen Municipal High Income Opportunity Fund
NMZ
$2.2B
$11.6M 0.4%
1,140,557
+416,337
+57% +$4.39M
INDV icon
42
Indivior Pharmaceuticals
INDV
$4.54B
$11.4M 0.39%
317,600
+96,177
+43% +$2.94M
IDV icon
43
iShares International Select Dividend ETF
IDV
$8.53B
$11.2M 0.39%
284,815
+14,726
+5% +$558K
MHD icon
44
BlackRock MuniHoldings Fund
MHD
$604M
$11.2M 0.39%
956,725
-129,981
-12% -$1.52M
OLMA icon
45
Olema Pharmaceuticals
OLMA
$1.04B
$11.2M 0.39%
447,046
+202,970
+83% +$3.61M
MMD
46
MainStay MacKay DefinedTerm Municipal Opportunities Fund
MMD
$281M
$11M 0.38%
739,494
+38,972
+6% +$585K
TEVA icon
47
Teva Pharmaceuticals
TEVA
$42.1B
$10.7M 0.37%
341,985
+22,962
+7% +$566K
MUA icon
48
BlackRock MuniAssets Fund
MUA
$519M
$10.5M 0.36%
976,962
+224,943
+30% +$2.43M
PANW icon
49
Palo Alto Networks
PANW
$314B
$10.4M 0.36%
56,677
+2,492
+5% +$503K
JAAA icon
50
Janus Henderson AAA CLO ETF
JAAA
$29.8B
$10.4M 0.36%
205,807
+10,408
+5% +$527K

Similar funds

Hennion & Walsh Asset Management's Q4 2025 Portfolio in Review

As of Q4 2025, Hennion & Walsh Asset Management held 1,008 positions worth $2.9B, up 5% from $2.76B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Hennion & Walsh Asset Management deployed $88.8M of net new capital in Q4 2025, opening 71 new positions and adding to 442 existing holdings. Its largest new stake was Schwab Fundamental International Large Company Index ETF: 53,014 shares worth $2.4M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Rhythm Pharmaceuticals, an estimated $3.59M trimmed.

  • Hennion & Walsh Asset Management's largest Q4 2025 buy was Schwab Fundamental International Large Company Index ETF: 53,014 shares worth $2.4M.
  • Hennion & Walsh Asset Management added most to Invesco Trust Investment Grade Municipals in Q4 2025, an estimated $4.8M increase.
  • Hennion & Walsh Asset Management's biggest Q4 2025 reduction was Rhythm Pharmaceuticals, cutting an estimated $3.59M.
  • Hennion & Walsh Asset Management fully exited Verona Pharma in Q4 2025, selling an estimated $19.8M.
  • Hennion & Walsh Asset Management's ten largest holdings make up 18% of its $2.9B portfolio in Q4 2025.
  • Hennion & Walsh Asset Management opened 71 new positions and closed 82 in Q4 2025.
  • Hennion & Walsh Asset Management's portfolio value rose 5% quarter-over-quarter to $2.9B.

Based on Hennion & Walsh Asset Management's 13F filing for Q4 2025, filed 14 Jan 2026.